reference/15988416

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/15988416

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase II\|Journal Article\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	3659
issn	1557-3265 1078-0432
issueIdentifier	12
pageRange	3652-3659
publicationName	Clinical cancer research : an official journal of the American Association for Cancer Research
startingPage	3652
bibliographicCitation	Llombart-Cussac A, Martin M, Harbeck N, Anghel RM, Eniu AE, Verrill MW, Neven P, De Grève J, Melemed AS, Clark R, Simms L, Kaiser CJ, Ma D. A randomized, double-blind, phase II study of two doses of pemetrexed as first-line chemotherapy for advanced breast cancer. Clin Cancer Res. 2007 Jun 15;13(12):3652–9. doi: 10.1158/1078-0432.ccr-06-2377. PMID: 17575230.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3be8bc29b160b5ded825977c9eb71a23 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_27391774d9cf76877f458bce79fbfa66 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6ee920573689aeec1de730f9c735ea9f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d089cd6bafdd57480d950a640719cd73 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6cc0d60f3c9465145834d6ce9d04b978 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ca9d71b8098d5da2478062e8bffa9e6e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_844bd74695d1b58e34e43bf1e6a2dcae http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9b9336c0d33d2316ec6835045b31db77 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fea039945c7e95bec911e0b9ed908ac1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7d5a0b935512b4c4a0a7a66767846aa9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_74dd295d62d35ea7121415ed10a52856 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_491beca168bade1d98a4c0ad1ca59cf1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_57b6377aaa7dc2ae4394fa0194ca0735 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-9237-3231
date	2007-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/17575230 https://doi.org/10.1158/1078-0432.ccr-06-2377
isPartOf	https://portal.issn.org/resource/ISSN/1078-0432 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8794 https://portal.issn.org/resource/ISSN/1557-3265
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	A Randomized, Double-Blind, Phase II Study of Two Doses of Pemetrexed as First-Line Chemotherapy for Advanced Breast Cancer
discusses	http://id.nlm.nih.gov/mesh/M0019167 http://id.nlm.nih.gov/mesh/M0009679 http://id.nlm.nih.gov/mesh/M0227083 http://id.nlm.nih.gov/mesh/M0009376 http://id.nlm.nih.gov/mesh/M0022794 http://id.nlm.nih.gov/mesh/M0022149 http://id.nlm.nih.gov/mesh/M0008658 http://id.nlm.nih.gov/mesh/M0001471
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D006147Q000031 http://id.nlm.nih.gov/mesh/D001943Q000188 http://id.nlm.nih.gov/mesh/D014408Q000032 http://id.nlm.nih.gov/mesh/D000964Q000008 http://id.nlm.nih.gov/mesh/D005971Q000008
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D019587 http://id.nlm.nih.gov/mesh/D005492 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D000964Q000009 http://id.nlm.nih.gov/mesh/D006147Q000009 http://id.nlm.nih.gov/mesh/D020133 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000068437 http://id.nlm.nih.gov/mesh/D012333Q000032 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D014805 http://id.nlm.nih.gov/mesh/D005971Q000009 http://id.nlm.nih.gov/mesh/D015870Q000187 http://id.nlm.nih.gov/mesh/D006147Q000008
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8661 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fdf9e942b6ca454f8cceff3e4117f2c9 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_6fca2b0eae7d6e3b9830baad3ef9a55b http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135410875 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_59a4ecce982b8c3efddb7b2964d06e3e http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID936 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_1325271ceb6ced42974ded478396cd87 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_6.3.2.17 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398658 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8321

Incoming Links

Predicate

Subject

http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53788923
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135945851
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128999113
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128204655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129439837
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID283537499
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128866026

Total number of triples: 85.